MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1

Atherosclerosis

Volumn 236, Issue 1, 2014, Pages

  Lv, Yun Cheng ^a   Tang, Yan Yan ^a   Peng, Juan ^a   Zhao, Guo Jun ^a   Yang, Jing ^a   Yao, Feng ^a   Ouyang, Xin Ping ^a   He, Ping Ping ^a   Xie, Wei ^a   Tan, Yu Lin ^a   Zhang, Min ^a   Liu, Dan ^a   Tang, Deng Pei ^c   Cayabyab, Francisco S ^c   Zheng, Xi Long ^d   Zhang, Da Wei ^e   Tian, Guo Ping ^b   Tang, Chao Ke ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b THE SECOND AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ABCA1; Atherosclerosis; Cholesterol accumulation; Macrophage; MiR 19b

Indexed keywords

ABC TRANSPORTER A1; ANTISENSE OLIGONUCLEOTIDE; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ESTER; COLLAGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 19B; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; ABCA1 PROTEIN, HUMAN; ABCA1 PROTEIN, MOUSE; MIRN19 MICRORNA, HUMAN; MIRN19 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ADULT; ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA ATHEROSCLEROSIS; AORTA ROOT; ARTICLE; BINDING SITE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FOAM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTIC DISEASES; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL LINE; COMPARATIVE STUDY; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SEQUENCE HOMOLOGY;

ANIMALS; AORTIC DISEASES; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; BASE SEQUENCE; CELL LINE; CHOLESTEROL; CHOLESTEROL ESTERS; COLLAGEN; FOAM CELLS; MACROPHAGES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; MOLECULAR SEQUENCE DATA; PLAQUE, ATHEROSCLEROTIC; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84905858359     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.07.005     Document Type: Article

References (43)

1. Pennings M., Meurs I., Ye D., Out R., Hoekstra M., Van Berkel T.J., et al. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett 2006, 580:5588-5596.
2. Moore K.J., Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011, 145:341-355.
3. Zhao Y., Van Berkel T.J., Van Eck M. Relative roles of various efflux pathways in net cholesterol efflux from macrophage foam cells in atherosclerotic lesions. Curr Opin Lipidol 2010, 21:441-453.
4. Ohashi R., Mu H., Wang X., Yao Q., Chen C. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 2005, 98:845-856.
5. Rosenson R.S., Brewer H.B., Davidson W.S., Fayad Z.A., Fuster V., Goldstein J., et al. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 2012, 125:1905-1919.
6. Hellerstein M., Turner S. Reverse cholesterol transport fluxes. Curr Opin Lipidol 2014, 25:40-47.
7. Ouimet M., Marcel Y.L. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol 2012, 32:575-581.
8. Attie A.D., Kastelein J.P., Hayden M.R. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. JLipid Res 2001, 42:1717-1726.
9. Lewis G.F., Rader D.J. New insights into the regulation of hdl metabolism and reverse cholesterol transport. Circ Res 2005, 96:1221-1232.
10. Oram J.F., Lawn R.M. ABCA1: the gatekeeper for eliminating excess tissue cholesterol. JLipid Res 2001, 42:1173-1179.
11. Singaraja R.R., Brunham L.R., Visscher H., Kastelein J.J.P., Hayden M.R. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003, 23:1322-1332.
12. Yu X.H., Jiang H.L., Chen W.J., Yin K., Zhao G.J., Mo Z.C., et al. Interleukin-18 and interleukin-12 together downregulate ATP-binding cassette transporter A1 expression through the interleukin-18R/nuclear factor-?B signaling pathway in THP-1 macrophage-derived foam cells. Circ J 2012, 76:1780-1791.
13. Mo Z.C., Xiao J., Liu X.H., Hu Y.W., Li X.X., Yi G.H., et al. AOPPs inhibits cholesterol efflux by down-regulating ABCA1 expression in a JAK/STAT signaling pathway-dependent manner. JAtheroscler Thromb 2011, 18:796-807.
14. Liu X.H., Xiao J., Mo Z.C., Yin K., Jiang J., Cui L.B., et al. Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells. JCardiovasc Pharmacol 2010, 56:309-319.
15. Hu Y.W., Ma X., Li X.X., Liu X.H., Xiao J., Mo Z.C., et al. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 2009, 204:e35-43.
16. Lv Y.C., Yin K., Fu Y.C., Zhang D.W., Chen W.J., Tang C.K. Posttranscriptional regulation of ATP-binding cassette transporter A1 in lipid metabolism. DNA Cell Biol 2013, 32:348-358.
17. Oram J.F., Heinecke J.W. ATP-binding cassette transporter a1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 2005, 85:1343-1372.
18. Zhang M., Wu J.F., Chen W.J., Tang S.L., Mo Z.C., Tang Y.Y., et al. MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages. Atherosclerosis 2014, 234:54-64.
19. de Aguiar Vallim T.Q., Tarling E.J., Kim T., Civelek M., Baldan A., Esau C., et al. MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor. Circ Res 2013, 112:1602-1612.
20. Kang M.H., Zhang L.H., Wijesekara N., de Haan W., Butland S., Bhattacharjee A., et al. Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145. Arterioscler Thromb Vasc Biol 2013, 33:2724-2732.
21. Bartel D. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
22. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
23. Fernandez-Hernando C., Ramirez C.M., Goedeke L., Suarez Y. MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 2013, 33:178-185.
24. Karunakaran D., Rayner K.J. MicroRNAs in cardiovascular health: from order to disorder. Endocrinology 2013, 154:4000-4009.
25. Bidzhekov K., Gan L., Denecke B., Rostalsky A., Hristov M., Koeppel T.A., et al. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost 2012, 107:619-625.
26. Liu G., Huang Y., Lu X.W., Lu M., Huang X.T., Li W.M., et al. Identification and characteristics of microRNAs with altered expression patterns in a rat model of abdominal aortic aneurysms. Tohoku J Exp Med 2010, 222:187-193.
27. Hu Y.W., Wang Q., Ma X., Li X.X., Liu X.H., Xiao J., et al. TGF-beta1 up-regulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells. JAtheroscler Thromb 2010, 17:493-502.
28. Lu Q., Tang S.L., Liu X.Y., Zhao G.J., Ouyang X.P., Lv Y.C., et al. Tertiary-butylhydroquinone upregulates expression of ATP-binding cassette transporter A1 via nuclear factor E2-related factor 2/heme oxygenase-1 signaling in THP-1 macrophage-derived foam cells. Circ J 2013, 77:2399-2408.
29. Liu X.Y., Lu Q., Ouyang X.P., Tang S.L., Zhao G.J., Lv Y.C., et al. Apelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C alpha signaling in THP-1 macrophage-derived foam cells. Atherosclerosis 2013, 226:398-407.
30. Zhang Y., Zanotti I., Reilly M.P., Glick J.M., Rothblat G.H., Rader D.J., et al. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces invivo. Circulation 2003, 108:661-663.
31. Wang D.L., Xia M., Yan X., Li D., Wang L., Xu Y.X., et al. Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circ Res 2012, 111:967-981.
32. Zhao G.J., Tang S.L., Lv Y.C., Ouyang X.P., He P.P., Yao F., et al. Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR-33 expression. PloS One 2013, 8:e74782.
33. Zhao G.J., Tang S.L., Lv Y.C., Ouyang X.P., He P.P., Yao F., et al. NF-kappaB suppresses the expression of ATP-binding cassette transporter A1/G1 by regulating SREBP-2 and miR-33a in mice. Int J Cardiol 2014, 171:e93-95.
34. Zhu Y., Li Y. Liver X receptors as potential therapeutic targets in atherosclerosis, clinical and investigative medicine. Medecine clinique et experimentale 2009, 32:E383-E394.
35. Fievet C., Staels B. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis. Biochem Pharmacol 2009, 77:1316-1327.
36. Sacco J., Adeli K. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol 2012, 23:220-225.
37. Moore K.J., Sheedy F.J., Fisher E.A. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013, 13:709-721.
38. Gantier M.P., Stunden H.J., McCoy C.E., Behlke M.A., Wang D., Kaparakis-Liaskos M., et al. AmiR-19 regulon that controls NF-kappaB signaling. Nucleic Acids Res 2012, 40:8048-8058.
39. Ye H.S., Liu X.W., Lv M., Wu Y.L., Kuang S.Z., Gong J., et al. MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia. Nucleic Acids Res 2012, 40:5201-5214.
40. Olive V., Bennett M.J., Walker J.C., Ma C., Jiang I., Cordon-Cardo C., et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev 2009, 23:2839-2849.
41. Mu P., Han Y.C., Betel D., Yao E., Squatrito M., Ogrodowski P., et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 2009, 23:2806-2811.
42. Boon R.A., Hergenreider E., Dimmeler S. Atheroprotective mechanisms of shear stress-regulated microRNAs. Thromb Haemost 2012, 108:616-620.
43. Rayner K.J., Moore K.J. MicroRNA control of high-density lipoprotein metabolism and function. Circ Res 2014, 114:183-192.